Clinical Research Unit for Skin, Allergy and Regeneration (CRUSAR), Institute of Medical Biology, Agency for Science, Technology and Research, Singapore, Singapore.
Dermatology. 2017;233(2-3):223-233. doi: 10.1159/000479150. Epub 2017 Aug 29.
Antiseptics, with a broader spectrum of antimicrobial efficacy, lower risk of antibiotic resistance development, and minimal collateral damage to host tissues, are important alternatives to control the bioburden in wounds. Povidone iodine (PVP-I), in use for several decades, has the broadest spectrum of activity, a persistent antimicrobial effect, an ability to penetrate biofilms, and a lack of acquired or cross-resistance. It demonstrates good skin tolerance and low cytotoxicity. However, some reports on PVP-I have raised concerns over allergy, ineffective penetration, and toxic effects on host cells. The majority of these concerns are based on in vitro or rodent wound studies with diverse study designs and outcomes; these results may not be directly applicable in the clinical reality in humans. In this paper, we discuss the efficacy and safety of PVP-I and outline its place in wound healing in Asia, based on an appraisal of recent literature and clinical practice across the region.
防腐剂具有更广泛的抗菌功效,发展抗生素耐药性的风险较低,对宿主组织的附带损伤最小,是控制伤口生物负荷的重要替代品。聚维酮碘(PVP-I)已使用了几十年,具有最广泛的活性谱、持久的抗菌作用、穿透生物膜的能力以及缺乏获得性或交叉耐药性。它表现出良好的皮肤耐受性和低细胞毒性。然而,一些关于 PVP-I 的报告引起了人们对过敏、渗透无效和对宿主细胞的毒性作用的担忧。这些担忧大多基于不同设计和结果的体外或啮齿动物伤口研究;这些结果可能不适用于人类的临床实际情况。在本文中,我们根据对该地区最近的文献和临床实践的评估,讨论了 PVP-I 的疗效和安全性,并概述了它在亚洲伤口愈合中的地位。